(Q24186387)

2

object named as

Jos H Verbeek

0 references

author name string

Jani H Ruotsalainen

3

0 references

Olumuyiwa A Ojo

4

0 references

Victor Nyange Bakhoya

Cochrane Database of Systematic Reviews

5

0 references

publication date

28 April 2015

0 references

2 May 2015

4 references

12 March 2019

13 March 2019

22 June 2019

17 June 2019

4 references

12 March 2019

13 March 2019

22 June 2019

17 June 2019

Creative Commons Attribution-NonCommercial-NoDerivs 3.0 Unported

4 references

12 March 2019

13 March 2019

22 June 2019

on focus list of Wikimedia project

17 June 2019

ScienceSource

0 references

cites work

Topical anti-inflammatory agents for seborrhoeic dermatitis of the face or scalp

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Clinical and biochemical assessment of maintenance treatment in chronic recurrent seborrheic dermatitis: randomized controlled study

19 March 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Comparing the efficacy of Emu oil with clotrimazole and hydrocortisone in the treatment of seborrheic dermatitis: A clinical trial

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Use of antifungal saponin SC-2 of Solanum chrysotrichum for the treatment of vulvovaginal candidiasis: in vitro studies and clinical experiences

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Skin diseases associated with Malassezia yeasts: facts and controversies

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

The biology and chemistry of antifungal agents: a review

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Topical antifungal agents for seborrheic dermatitis: systematic review and meta-analysis.

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Efficacy of a piroctone olamine/climbazol shampoo in comparison with a zinc pyrithione shampoo in subjects with moderate to severe dandruff

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Clinical practice. Seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Nudging hair shedding by antidandruff shampoos. A comparison of 1% ketoconazole, 1% piroctone olamine and 1% zinc pyrithione formulations

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Clinical efficacies of shampoos containing ciclopirox olamine (1.5%) and ketoconazole (2.0%) in the treatment of seborrhoeic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Seborrheic dermatitis: an overview

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Ciclopirox 1% shampoo for the treatment of seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Oral terbinafine in the treatment of multi-site seborrhoic dermatitis: a multicenter, double-blind placebo-controlled study

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Role of antifungal agents in the treatment of seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Skin diseases associated with Malassezia species

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

A multicenter randomized trial of ketoconazole 2% and zinc pyrithione 1% shampoos in severe dandruff and seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Effect of ketoconazole 1% and 2% shampoos on severe dandruff and seborrhoeic dermatitis: clinical, squamometric and mycological assessments

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Treatment of seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Antifungal agents: mode of action, mechanisms of resistance, and correlation of these mechanisms with bacterial resistance

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Seborrhoeic dermatitis is not caused by an altered immune response to Malassezia yeast

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

A randomized, double-blind, placebo-controlled trial of ketoconazole 2% shampoo versus selenium sulfide 2.5% shampoo in the treatment of moderate to severe dandruff

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Seborrhoea is not a feature of seborrhoeic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

The response of seborrhoeic dermatitis to ketoconazole

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Use of topical lithium succinate for seborrhoeic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Piadar (Ladar): new antimycotic drug containing the antifungal agent siccanin (author's transl)

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Comparison the efficacy of fluconazole and terbinafine in patients with moderate to severe seborrheic dermatitis

27 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Pimecrolimus cream 1% vs. betamethasone 17-valerate 0.1% cream in the treatment of seborrhoeic dermatitis. A randomized open-label clinical trial

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Treatment of dandruff with a 2% ketoconazole scalp gel. A double-blind placebo-controlled study

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Seborrhoeic dermatitis and Pityrosporum orbiculare: treatment of seborrhoeic dermatitis of the scalp with miconazole-hydrocortisone (Daktacort), miconazole and hydrocortisone

30 May 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Rationale of frequency of use of ciclopirox 1% shampoo in the treatment of seborrheic dermatitis: results of a double-blind, placebo-controlled study comparing the efficacy of once, twice, and three times weekly usage

30 May 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Efficacy of different concentrations of ciclopirox shampoo for the treatment of seborrheic dermatitis of the scalp: results of a randomized, double-blind, vehicle-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

A comparison of hair quality and cosmetic acceptance following the use of two anti-dandruff shampoos.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Randomized, placebo-controlled, double-blind study on clinical efficacy of ciclopiroxolamine 1% cream in facial seborrhoeic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Clinical and mycological evaluation of therapeutic effectiveness of Solanum chrysotrichum standardized extract on patients with Pityriasis capitis (dandruff). A double blind and randomized clinical trial controlled with ketoconazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

An open, randomized, prospective, comparative study of topical pimecrolimus 1% cream and topical ketoconazole 2% cream in the treatment of seborrheic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Treatment and prophylaxis of seborrheic dermatitis of the scalp with antipityrosporal 1% ciclopirox shampoo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Ciclopiroxolamine cream for treating seborrheic dermatitis: a double-blind parallel group comparison

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Pimecrolimus 1% cream, methylprednisolone aceponate 0.1% cream and metronidazole 0.75% gel in the treatment of seborrhoeic dermatitis: a randomized clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Is topical metronidazole effective in seborrheic dermatitis? A double-blind study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

A double-blind placebo-controlled study of ketoconazole + desonide gel combination in the treatment of facial seborrheic dermatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Evaluation of the efficacy and tolerability of oral terbinafine (Daskil) in patients with seborrhoeic dermatitis. A multicentre, randomized, investigator-blinded, placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Therapeutic efficacy of anti-dandruff shampoos: a randomized clinical trial comparing products based on potentiated zinc pyrithione and zinc pyrithione/climbazole.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

A randomised, single-blind, single-centre clinical trial to evaluate comparative clinical efficacy of shampoos containing ciclopirox olamine (1.5%) and salicylic acid (3%), or ketoconazole (2%, Nizoral) for the treatment of dandruff/seborrhoeic derm

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

The frequency of common skin conditions in preschool-aged children in Australia: seborrheic dermatitis and pityriasis capitis (cradle cap).

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Interventions for infantile seborrhoeic dermatitis (including cradle cap)

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Five new steroidal saponins from Solanum chrysotrichum leaves and their antimycotic activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

21 January 2018

Seborrheic Dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Clinical study of sertaconazole 2% cream vs. hydrocortisone 1% cream in the treatment of seborrheic dermatitis.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

A double blind study of the effectiveness of sertaconazole 2% cream vs. metronidazole 1% gel in the treatment of seborrheic dermatitis

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Efficacy of topical 4% Quassia amara gel in facial seborrheic dermatitis:a randomized, double-blind, comparative study

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Randomized study comparing the efficacy and tolerance of a lipohydroxy acid shampoo to a ciclopiroxolamine shampoo in the treatment of scalp seborrheic dermatitis

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

A novel foam formulation of ketoconazole 2% for the treatment of seborrheic dermatitis on multiple body regions.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Safety and efficacy of ciclopirox 1% shampoo for the treatment of seborrheic dermatitis of the scalp in the US population: results of a double-blind, vehicle-controlled trial

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Successful treatment of dandruff with 1.5% ciclopirox olamine shampoo in Korea

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Ciclopirox gel for seborrheic dermatitis of the scalp

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Does 5% tea tree oil shampoo reduce dandruff?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Lithium gluconate in the treatment of seborrhoeic dermatitis: a multicenter, randomised, double-blind study versus placebo

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Does treatment with topical metronidazole improve seborrheic dermatitis?

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Randomised double blind controlled trial of 2% ketoconazole cream versus 0.05% clobetasol 17-butyrate cream in seborrhoeic dermatitis.

29 November 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4448221

Efficacy of a new antidandruff thermophobic foam: a randomized, controlled, investigator-blinded trial vs. ketoconazole 2% scalp fluid

29 November 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

Ketoconazole 2% cream versus hydrocortisone 1% cream in the treatment of seborrheic dermatitis. A double-blind comparative study

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

The antidandruff efficacy of a shampoo containing piroctone olamine and salicylic acid in comparison to that of a zinc pyrithione shampoo

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Treatment of seborrhoeic dermatitis with ketoconazole: II. Response of seborrhoeic dermatitis of the face, scalp and trunk to topical ketoconazole

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

A double-blind trial of treatment of seborrhoeic dermatitis with 2% ketoconazole cream compared with 1% hydrocortisone cream

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Successful treatment and prophylaxis of scalp seborrhoeic dermatitis and dandruff with 2% ketoconazole shampoo: results of a multicentre, double-blind, placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Efficacious and safe management of moderate to severe scalp seborrhoeic dermatitis using clobetasol propionate shampoo 0·05% combined with ketoconazole shampoo 2%: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Topical lithium succinate ointment (Efalith) in the treatment of AIDS-related seborrhoeic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Kefoconazofe 2% Emulsion in the Treatment of Seborrheic Dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Comparative efficacy and safety of bifonazole 1% cream and the corresponding base preparation in the treatment of seborrhoeic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Treatment of seborrhoeic dermatitis of the scalp with a topical solution of urea, lactic acid, and propylene glycol (K301): results of two double-blind, randomised, placebo-controlled studies

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Metronidazole 0.75% gel vs. ketoconazole 2% cream in the treatment of facial seborrheic dermatitis: a randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Topical Metronidazole in Seborrheic Dermatitis – A Double-Blind Study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Comparative study of ketoconazole 2% foaming gel and betamethasone dipropionate 0.05% lotion in the treatment of seborrhoeic dermatitis in adults

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Efficacy of oral fluconazole in the treatment of seborrheic dermatitis: a placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

[Study on the usefulness of rinse containing miconazole nitrate for treatment of dandruff--a double-blind, comparative study]

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

The efficacy of 1% metronidazole gel in facial seborrheic dermatitis: a double blind study

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021

Investigations of seborrheic dermatitis. Part II. Influence of itraconazole on the clinical condition and the level of selected cytokines in seborrheic dermatitis

1 reference

https://api.crossref.org/works/10.1002%2F14651858.CD008138.PUB2

7 January 2021